Schechter Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Schechter Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $92,601 - $104,992	-1,930 Reduced 12.61%	13,374 $725,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $550,296 - $656,655	-11,351 Reduced 42.58%	15,304 $785,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $202,788 - $226,749	3,503 Added 15.13%	26,655 $1.55 Million
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $68,169 - $75,691	-1,070 Reduced 4.42%	23,152 $1.48 Million
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $208,892 - $236,930	-3,179 Reduced 11.6%	24,222 $1.68 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $273,577 - $323,954	3,995 Added 17.07%	27,401 $1.97 Million
Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $347 - $205,547	2,675 Added 12.9%	23,406 $1.66 Million
Q2 2022 Nov 03, 2022	BUY	$72.62 - $79.98 $1.51 Million - $1.66 Million	20,731 New	20,731 $1.6 Million
Q1 2022 Nov 18, 2022	SELL	$61.48 - $73.72 $230,181 - $276,007	-3,744 Reduced 16.0%	19,662 $1.44 Million
Q4 2021 Dec 27, 2022	SELL	$53.63 - $62.52 $336,635 - $392,438	-6,277 Reduced 26.82%	17,129 $1.07 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Schechter Investment Advisors, LLC with notifications on news.